News & Updates

High adiposity levels are associated with the risk of colorectal cancer (CRC), suggest the results of a systematic review. However, standardization is necessary to improve understanding of the link between CRC and adiposity to enable comparisons across papers.

Patients with systemic lupus erythematosus (SLE) with low levels of vitamin D tend to have a more severe form of the disease, according to a systematic review and meta-analysis.

A recent study has observed the association of bisphenol A (BPA) and its substitutes with specific metabolic diseases (MDs).

Glycaemic outcomes following sleeve gastrectomy (SG) vary by race and ethnicity, with non-Hispanic Black (NHB) participants showing less favourable outcomes, reports a study.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have the potential to reduce the frequency of migraines even in patients who do not lose weight—an effect that may be related to a reduction in intracranial pressure, according to a pilot prospective observational study.

Patients without diabetes who use GLP-1 receptor agonists (RAs) display a lower risk of primary open-angle glaucoma (POAG) and ocular hypertension than those who use other weight-loss therapies at 3- and 5-year intervals, a study has shown.

Obesity shows a significant relationship with several indices of asymptomatic cardiac remodelling and vascular atherosclerosis, according to a study. Moreover, this association is mediated by systolic blood pressure (BP).

For adult patients with type 2 diabetes (T2D) who are naïve to insulin, a once-weekly fixed-dose efsitora regimen is noninferior to once-daily glargine at reducing blood glucose levels, according to the phase III treat-to-target QWINT-1 trial.

Two large prospective cohorts show no evidence of an association between the use of oral contraceptives and the risk of liver cancer.

In the treatment of patients with type 2 diabetes, sulfonylureas pose an increased risk of major adverse cardiovascular events (MACE) compared with dipeptidyl peptidase 4 inhibitors (DPP4is), according to a study.